SCHEMBL22459375

SCHEMBL22459375

C=C(COC)C(=O)OCCCc1ccc(-c2ccc(OCCOC(=O)C(=C)COC)c(F)c2)c(F)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM5 P08912 1/20 0.35
▸ CHRM1 P11229 1/20 0.35
▸ CHRM3 P20309 1/20 0.35
▸ RARB P10826 1/20 0.35
▸ FFAR4 Q5NUL3 2/20 0.35
▸ FFAR1 O14842 2/20 0.35
▸ GRM2 Q14416 1/20 0.34
▸ EGFR P00533 1/20 0.34
▸ RARG P13631 1/20 0.34
▸ KDM1A O60341 1/20 0.33
▸ PRKAB2 O43741 1/20 0.33
▸ PRKAG1 P54619 1/20 0.33
▸ PRKAA2 P54646 1/20 0.33
▸ PRKAA1 Q13131 1/20 0.33
▸ PRKAG3 Q9UGI9 1/20 0.33
▸ PRKAG2 Q9UGJ0 1/20 0.33
▸ PRKAB1 Q9Y478 1/20 0.33
▸ S1PR1 P21453 1/20 0.33
▸ PPARD Q03181 1/20 0.33
▸ PPARA Q07869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22459691 0.90 S1PR1 (0.41) CHRM5CHRM1CHRM3RARBFFAR1
SCHEMBL22459329 0.88 RARB (0.36) RARBFFAR4KDM1A
SCHEMBL22561074 0.87 S1PR1 (0.42) RARBFFAR1EGFRRARGS1PR1
SCHEMBL22459611 0.86 RARB (0.43) RARBFFAR4FFAR1RARGKDM1A
SCHEMBL22459320 0.85 RARB (0.41) RARBKDM1AS1PR1
SCHEMBL22459777 0.84 RARB (0.43) RARBFFAR4FFAR1RARGS1PR1
SCHEMBL22459865 0.84 S1PR1 (0.37) RARBFFAR4FFAR1RARGS1PR1
SCHEMBL22561041 0.82 S1PR1 (0.44) RARBFFAR4FFAR1S1PR1
SCHEMBL22459333 0.82 POLB (0.37) CHRM5CHRM1CHRM3RARBKDM1A
SCHEMBL22459402 0.82 PDE4A (0.36) FFAR4FFAR1EGFRS1PR1PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3725764-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE JNC Corporation (JP) 2020-10-21 — — EP disclosed
US-20200299578-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2020-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200299578-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, CCND1, CPNE4 CHRM5 2095/4885CHRM1 235/4885CHRM3 2762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback